Navigation Links
ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
Date:12/17/2009

='External Link';s.eVar3=s.prop5;s.prop15='79490252';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.anadyspharma.com/">www.anadyspharma.com. A telephone replay with slides will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 75270153. The webcast and telephone replay will be available through December 31, 2009.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to (i) the expected timing for enrolling the next cohort in the ANA598 Phase II study and for receiving 12 week data from the 200 mg bid cohort and 4 and 12 week data from the 400 mg bid cohort; (ii) the prospects of ANA598 being able to contribute to long-term treatment outcome as measured by SVR and the hope that ANA598 will be established as the leading non-nucleoside in HCV, suitable for combination with current SOC as well as with other direct antivirals currently in development; (iii) the ability for patients to achieve EVR and SVR in the ANA598 Phase II study; and (iv) assessments of the safety and tolerability profile of ANA598 based on the interim 4 week analysis. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 will not have unforeseen safety issues or will continue to have favorable results as the Phase II trial progresses. In addition, Anadys' results may be affected by competition from other biotechno
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
11. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- This study provides an analysis of the ... nuclear imaging informatics, PET imaging informatics, and multimodality ... size of the market based on its historic ... growth based on the current drivers and restraints, ... the broader markets for imaging equipment, advanced visualization, ...
(Date:9/30/2014)...  Decision Resources Group finds that the Asia Pacific ... China , India , ... through 2023. Dental implant procedure volumes will grow as physicians are ... Other key findings from Decision Resources Group,s coverage of the ... , Dental implant penetration: Penetration of dental implants among the ...
(Date:9/30/2014)... A study using a relatively new imaging ... at the composition of carotid artery disease and has ... the disease, a leading cause of stroke. ... September 2010 and May 2012, was featured in the ... American College of Cardiology (JACC) Cardiovascular Interventions. Interventional ...
Breaking Medicine Technology:Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
(Date:9/30/2014)... Health Day Reporter TUESDAY, ... who are overweight or obese when diagnosed appear to ... weight-related cancer, new research suggests. , , The finding ... only the potential for developing other cancers associated with ... who reported being overweight or obese prior to diagnosis ...
(Date:9/30/2014)... is the leading cause of cancer death in women, ... many medical professionals encourage women to get mammograms, even ... minority of suspicious mammograms actually leads to a cancer ... for women and their familiesnot to mention the time, ... biopsies. , Recently, a different type of test, ...
(Date:9/30/2014)... 2014 Keystone Symposia will convene the first conference ... 2014-15 Global Health Series on "The Modes of ... immediately following the conclusion of the Grand Challenges ... part of the Keystone Symposia Global Health Series, supported ... also funded travel awards for 36 investigators from developing ...
(Date:9/30/2014)... A new study of 58 women conducted by ... on metabolism after eating a high-fat meal equivalent to a ... restaurant, about 930 calories and 60 grams of fat. Researchers ... for 7 hours, conducting the study twice on each woman. ... stressful event in their lives during the previous 24 hours ...
(Date:9/30/2014)... Integrated Medicine Alliance , Monmouth ... new medical specialty practice through a unique partnership with ... be located within the company’s Shrewsbury location and will ... Tawfik of American Heart Center, P.C., a highly regarded ... offer Integrated Medicine Alliance patients top notch cardiovascular care ...
Breaking Medicine News(10 mins):Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 2Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 3Health News:'Virtual breast' could improve cancer detection 2Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 3Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2
... with the WHO International Agency for Research on Cancer ... to the list of pernicious cancers where alcohol is ... threatfor instance, just one drink a day increases a ... light of this disturbing trend, the Toronto Cancer Prevention ...
... Belt Market; 8 New Office Locations in the, Southeast Region ... ... Revenue Base by 35%, DALLAS, Oct. 29 Crdentia Corp. ... has completed the acquisition of ATS Health Services, a provider of,temporary ...
... new ... nationwide survey shows, JACKSONVILLE, Fla., Oct. 29 ... on November 4 and see fewer hours of,daylight, findings from a ... may not be seeing while,driving in the dark. Of further concern, ...
... the World Research Group ... Management Conference in Chicago, DALLAS, Oct. 29 ... to help large,employers meet the changing healthcare needs of ... retirement years. Informed Health Navigator is an innovative ...
... German team reports , MONDAY, Oct. 29 (HealthDay News) -- ... an unborn baby after premature rupture of the fetal membranes ... membranes burst during the 20th week of pregnancy, the unborn ... the Bonn University Clinic in Germany. Not only was there ...
... 29 /Xinhua-PRNewswire/ -- China Health Resource,Inc. (OTC Bulletin ... a joint development contract of the Chuan DAR ... Derentang to establish a Chuan DAR,Sale Center, specializing ... processed products. The cooperation will greatly boost the ...
Cached Medicine News:Health News:Alcohol and cancer -- recent research and prevention opportunities 2Health News:Crdentia Acquires ATS Health Services 2Health News:Crdentia Acquires ATS Health Services 3Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 2Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 3Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 4Health News:ACS Launches Product to Help Employers Navigate Health Choices For Employees Entering Retirement Years 2Health News:Fetal Surgery Saves Baby After Early 'Water Break' 2Health News:CHRI Signs Joint Market Development Contract with Derentang 2
The Nicolet Bravo™ is a Multi-application system that can configure to meet the needs of neurophysiology department....
... Katena Products, Inc. is ... company dedicated exclusively to ophthalmic ... products to over 7,000 customers ... through a global network of ...
... food, exercise, stress . . . Theyre ... overall health. Unfortunately, its difficult, and often ... on a daily basis. Its even more ... submit the information to a care provider ...
... Managing diabetes requires making decisions about insulin ... exercise. These decisions are guided by data ... information, and by the patterns that can ... Care Providers when the data is presented ...
Medicine Products: